Spanish Guidelines on Treatment of Bronchiectasis in Adults
Arch Bronconeumol (Engl Ed). 2018 Feb;54(2):88-98.
doi: 10.1016/j.arbres.2017.07.016.
Epub 2017 Nov 9.
[Article in
English,
Spanish]
Authors
Miguel Ángel Martínez-García
1
, Luis Máiz
2
, Casilda Olveira
3
, Rosa Maria Girón
4
, David de la Rosa
5
, Marina Blanco
6
, Rafael Cantón
7
, Montserrat Vendrell
8
, Eva Polverino
9
, Javier de Gracia
10
, Concepción Prados
11
Affiliations
- 1 Servicio de Neumología, Hospital Universitario y Politécnico la Fe, Valencia, España. Electronic address: [email protected].
- 2 Unidad de bronquiectasias y fibrosis quística, Servicio de Neumología, Hospital Universitario Ramón y Cajal, Madrid, España.
- 3 Servicio de Neumología, Hospital Regional Universitario de Málaga, Instituto de Biomedicina (IBIMA), Universidad de Málaga, Málaga, España.
- 4 Servicio de Neumología, Hospital Universitario la Princesa, Madrid, España.
- 5 Unidad de Neumología, Hospital Platón, Barcelona, España.
- 6 Servicio de Neumología, Complejo Hospitalario Universitario A Coruña, A Coruña, España.
- 7 Servicio de Microbiología, Hospital Universitario Ramón y Cajal e Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, España.
- 8 Servicio de Neumología, Hospital Universitario Dr Josep Trueta, Grupo Bronquiectasias IDIBGI, Universitat de Girona, Girona, España.
- 9 Institut de Recerca Vall d'Hebrón (VHIR), Servicio de Neumología, Hospital Universitari Vall d'Hebron (HUVH), Barcelona, España.
- 10 Servicio de Neumología, Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, CIBER Enfermedades Respiratorias (CB06/06/0030), Barcelona, España.
- 11 Unidad de bronquiectasias y fibrosis quística, Servicio de Neumología, Hospital Universitario La Paz y Hospital Universitario La Paz-Cantoblanco-Carlos III, Madrid, España.
Abstract
In 2008, the Spanish Society of Pulmonology (SEPAR) published the first guidelines in the world on the diagnosis and treatment of bronchiectasis. Almost 10 years later, considerable scientific advances have been made in both the treatment and the evaluation and diagnosis of this disease, and the original guidelines have been updated to include the latest therapies available for bronchiectasis. These new recommendations have been drafted following a strict methodological process designed to ensure quality of content, and are linked to a large amount of online information that includes a wealth of references. The guidelines are focused on the treatment of bronchiectasis from both a multidisciplinary perspective, including specialty areas and the different healthcare levels involved, and a multidimensional perspective, including a comprehensive overview of the specific aspects of the disease. A series of recommendations have been drawn up, based on an in-depth review of the evidence for treatment of the underlying etiology, the bronchial infection in its different forms of presentation using existing therapies, bronchial inflammation, and airflow obstruction. Nutritional aspects, management of secretions, muscle training, management of complications and comorbidities, infection prophylaxis, patient education, home care, surgery, exacerbations, and patient follow-up are addressed.
Keywords:
Agudizaciones; Antibióticos inhalados; Bronchiectasis; Bronquiectasias; Chronic bronchial infection; Computed tomography; E-FACED; Exacerbations; FACED; Fisioterapia respiratoria; Infección bronquial crónica; Inhaled antibiotics; Macrolides; Macrólidos; Mucolytics; Mucolíticos; Pseudomonas aeruginosa; Respiratory physiotherapy; Tomografía computarizada.
Copyright © 2017 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Administration, Inhalation
-
Adult
-
Anti-Bacterial Agents / therapeutic use*
-
Bronchiectasis / etiology
-
Bronchiectasis / therapy*
-
Bronchitis / drug therapy*
-
Chronic Disease
-
Exercise Therapy
-
Expectorants / therapeutic use
-
Humans
-
Lung Transplantation
-
Malnutrition / therapy
-
Pseudomonas Infections / complications
-
Pseudomonas Infections / drug therapy*
-
Pseudomonas aeruginosa*
Substances
-
Anti-Bacterial Agents
-
Expectorants